Blog

Pharmacelera’s CEO selected as member of the Industrial Advisory Committee (IAC) of PRACE

Pharmacelera's CEO, Enric Gibert has been selected as member of the Industrial Advisory Committee (IAC) of PRACE. This membership is aligned with Pharmacelera's strategy of becoming a leader in high performance computing for drug design and influencing the European HPC agenda. Pharmacelera's expertise in parallelization and hardware acceleration is used in Pharmacelera's products (PharmScreen and…
Read more

Pharmacelera in the DES2016

Pharmacelera has been selected to participate in the Digital Enterprise show 2016. A selected group of the most innovative startups in the industry sector have been invited to present their projects. Enric Gibert, Pharmacelera's CEO, attended the event and showcased the capabilities of PharmScreen and PharmQSAR and how they can improve productivity in the pharmaceutical…
Read more

New paper published in the Journal of Molecular Modeling

[span4] Our work in new hydrophobic molecular models for 3D molecule representation has been just published in the Journal of Molecular Modeling. This paper is the result of the work of researchers from the Computational Biology and Drug Design Group from the University of Barcelona, the Dipartamento di Scienze degli Alimenti from the University of…
Read more

Pharmacelera selected to participate in the TEA program from IESE and ACCIÓ

Pharmacelera has been selected to participate in the "Taller Estratégico de Acceleración" (TEA) program, organized by IESE Business School and Acció. The TEA program is oriented to a restricted group of companies with technological background and high growth perspectives. This program is focused on improving the capacities of these companies and help them in the…
Read more